{
  "ticker": "INBX",
  "success": true,
  "price": {
    "current": 72.56,
    "currency": "USD",
    "day_high": 75.25,
    "day_low": 72.4,
    "52_week_high": 94.565,
    "52_week_low": 10.805
  },
  "market_cap": {
    "value": 1055293568.0,
    "currency": "USD"
  },
  "shares_outstanding": 14543738.0,
  "volume": {
    "last": 184688,
    "average_30d": 202986
  },
  "valuation": {
    "pe_ratio": null,
    "forward_pe": -15.243696,
    "price_to_book": 28.566929
  },
  "company_info": {
    "name": "Inhibrx Biosciences, Inc.",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "balance_sheet": {
    "success": true,
    "period_date": "2025-09-30",
    "total_assets": 177471000.0,
    "total_liabilities": 140641000.0,
    "stockholders_equity": 36830000.0,
    "cash": 153088000.0,
    "marketable_securities": null,
    "total_liquidity": 153088000.0,
    "total_debt": 106905000.0,
    "long_term_debt": 99917000.0,
    "current_debt": 2247000.0,
    "error": null
  },
  "cash_flow": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_cash_flow": -33824000.0,
    "free_cash_flow": -33834000.0,
    "investing_cash_flow": -7000.0,
    "financing_cash_flow": 352000.0,
    "error": null
  },
  "income_statement": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_expense": 33812000.0,
    "research_and_development": 28535000.0,
    "interest_expense": 3181000.0,
    "net_income": -35256000.0,
    "revenue": 0.0,
    "gross_profit": null,
    "ebitda": -31492000.0,
    "error": null
  },
  "data_quality": {
    "flags": [],
    "has_price": true,
    "has_market_cap": true,
    "has_volume": true,
    "has_balance_sheet": true,
    "has_cash_flow": true,
    "has_income_statement": true
  },
  "provenance": {
    "source": "Yahoo Finance via yfinance",
    "timestamp": "2026-01-29T16:48:14.951654",
    "url": "https://finance.yahoo.com/quote/INBX",
    "data_hash": "e2d89bb717b74a87"
  }
}